Detection of Candida auris and its antifungal susceptibility: first report from Bangladesh

Authors

  • Subarna Dutta Department of Microbiology, BIRDEM General Hospital, Shahbag, Dhaka, Bangladesh
  • Md Hasibur Rahman Department of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh
  • Kazi Shakhawath Hossain Department of Botany, Faculty of Life & Earth Science, Jagannath University, Dhaka, Bangladesh
  • Jalaluddin Ashraful Haq Department of Microbiology, Ibrahim Medical College, Shahbag Avenue, Dhaka, Bangladesh

Keywords:

Detection of Candida, antifungal susceptibility

Abstract

Background and objectives: Candida auris is an emerging multidrug-resistant fungal pathogen that has been associated with nosocomial infections with a high mortality. The organism has been reported from several countries of the world except Bangladesh. The present study describes the presence of C. auris in clinical samples obtained from a large hospital of Dhaka city, Bangladesh.

Materials and methods: The A total of 100 Candida species isolated from different clinical samples were purposively included in the present study. Samples were obtained from patients attending a 750 bed hospital of Dhaka city. C. auris was identified by growth characteristics, biochemical and carbohydrate assimilation test and further confirmed by polymerase chain reaction and sequencing using ITS1 and ITS2 targeting the conserved regions of 5.8S rRNA. Antifungal susceptibility of identified C. auris was performed by disk diffusion and minimum inhibitory concentration (MIC) methods.

Results: Out of 100 Candida sp. tested, 21 isolates were identified as C. auris. Of the 21 C. auris, 14 (66.7%) were isolated from blood samples and the remaining 7 (33.4%) were from urine. Most of the C. auris isolated were from patients admitted in intensive care units. Out of 21 C. auris, 17 (81.0%), 7 (33.3%) and 3 (14.3%) were sensitive to amphotericin B, fluconazole and voriconazole respectively by disk diffusion method. Out of 14 fluconazole resistant isolates, 5 were susceptible dose-dependent (SS-D) by MIC method.

Conclusion: The present study is the first report demonstrating the presence of C. auris in clinical samples obtained from a large hospital of Bangladesh. Majority of isolates showed resistance to fluconazole and variable susceptibility to other antifungal agents. Further study is suggested to find its true magnitude and its susceptibility pattern to a range of antifungal agents.

Ibrahim Med. Coll. J. 2019; 13(2): 18-22

Downloads

Download data is not yet available.
Abstract
70
PDF
40

Downloads

Published

2020-02-03

How to Cite

Dutta, S., Rahman, M. H., Hossain, K. S., & Haq, J. A. (2020). Detection of Candida auris and its antifungal susceptibility: first report from Bangladesh. IMC Journal of Medical Science, 13(2), 18–22. Retrieved from https://banglajol.info/index.php/IMCJMS/article/view/45276

Issue

Vol. 13 No. 2 (2019)

Section

Original Articles

License

Authors who publish in IMCJMS agree to the following terms that:

  1. Authors retain copyright and grant IMCJMS the right of first publication of the work.

  2. Creative Commons Licence
    Articles in IMCJMS are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.